Navigation Links
Cryo-Cell International, Inc. Reports First Quarter 2008 Results
Date:4/10/2008

p>As of February 29, 2008, the Company had approximately $4.2 million in available cash, cash equivalents, marketable securities and other investments. The Company had no long-term debt at the end of the quarter.

On November 1, 2007 Cryo-Cell commercially launched the C'elle menstrual stem cell preservation and storage service, an innovative and proprietary new service based on the Company's extensive patent portfolio of intellectual property. C'elle represents a major milestone in the Company's strategic plan to achieve product diversification, and the new service is expected to contribute to future revenue growth and earnings. In parallel, Cryo-Cell is also implementing plans to license C'elle technology in strategic global markets that may potentially serve to generate additional new sources of revenue.

"We are encouraged by Cryo-Cell's improved performance in the first quarter of 2008. In accordance with our long-term strategic plan, we believe that the Company is progressing well in the early phase of fiscal 2008," stated Mercedes Walton, Chairman and Chief Executive Officer. "In 2006, following nine consecutive quarters of profitability spanning the first quarter of 2004 through the second quarter of 2006, Cryo-Cell's Board of Directors made the deliberate decision to forsake continued near-term profitability in order to invest in the long-term growth of our business. At this juncture, we are pleased with early indicators that we believe reflect growing interest in C'elle, as both a standalone direct-to-consumer service and as a uniquely differentiated combination service offered along with our signature UCord(R) product."

"Notwithstanding formidable challenges associated with new product development, intensified industry competition and the overall impact of the economy on discretionary consumer spending, the Company has maintained a steadfast focus on our comprehensive strategic plan to achieve product diversification and advance commerc
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
2. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
3. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
4. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
5. Corium International, Inc. Announces Appointment of Phyllis Gardner, M.D. and Daniel G. Welch to Board
6. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
7. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
8. Bio-Clean International, Inc. to Present at Bluechip Capital Investment Forum
9. MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer
10. VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
11. Sangui BioTech International, Inc., Reports Sales Increase, Continued Losses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014 With a larger, ... the new Cole-Parmer® Digital Gear Pump Drive ... to operate for automated process applications. , Simply ... The batch count function counts down and displays ... tracks amount dispensed across multiple cycles. View the ...
(Date:7/21/2014)... , July 21, 2014 ... & USA Cancer Biomaker ... Forecasts ResearchMoz presents this most up-to-date ...   to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, ... Pipeline Analysis. GLOBAL & ...
(Date:7/18/2014)... TARRYTOWN, N.Y. , July 18, 2014 ... report its second quarter 2014 financial and operating results ... markets open.  The Company will host a conference call ... day. Conference Call InformationTo access this ...  A link to the webcast may be accessed from ...
(Date:7/18/2014)... July 18, 2014  Neurotrope, Inc. (OTCQB: NTRP) today ... Directors appointed Co-Chairmen Charles S. Ramat and ... an interim basis, effective immediately. Messrs. Ramat and Freiman ... longer Chief Executive Officer of Neurotrope Bioscience, Inc., (a ... whose employment agreement with Neurotrope Bioscience Inc. terminated as ...
Breaking Biology Technology:New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 2Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 3Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 4Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 5Global & USA Cancer Biomaker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis) - Market Size, Trends, and Forecasts A 6Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4
... , , , Multiporator , , , , , ... Transfection Protocol , Protocol No. 4308 915.026 11/2001 , ... , , , ... line), , , ...
... , , , Multiporator / Electroporator 2510 , , , , , ... Transformation Protocol , Protocol No. 4308 915.525 01/2002 , ... , , , ... , Cell type , Bacteria, gram positive, ...
... Multiporator / Electroporator 2510 , , , , , , , ... Protocol No. 4308 915.540 07/2002 , , ... , , Microorganism , ... Cell type , Bacteria, gram positive, , ...
Cached Biology Technology:Sp20-Ag14 2Sp20-Ag14 3Nocardia asteroides 2Pediococcus spp. 2
(Date:7/21/2014)... Irvine, Calif., July 21, 2014 Dysfunction in ... about 2,000 genes in the brain,s prefrontal cortex ... complex neuropsychiatric disorders, such as schizophrenia, according to ... gene activity in brain cells that receive this ... deficiencies can affect a variety of behavioral and ...
(Date:7/21/2014)... satellites detected 154 hotspots in areas across Riau province ... had increased again following a decline in rainfall. ... far higher than what had been reported one day ... hotspots were scattered in six regencies and municipalities, most ... and the related haze it creates could potentially spread ...
(Date:7/21/2014)... change, due to greenhouse gasses emitted by livestock. New ... and that beef cattle are responsible for far more ... is published by Climactic Change . , ... to climate change. It is released by vehicles, industry, ... greenhouse gas totals. But methane and nitrous oxide are ...
Breaking Biology News(10 mins):UCI researchers find epigenetic tie to neuropsychiatric disorders 2Climate: Meat turns up the heat 2
... with a large-scale "geoengineering" fix, such as having a ... or building tens of millions of chemical filter systems ... But Richard Turco, a professor in ... a member and founding director of UCLA,s Institute of ...
... Rochester have designed a gene that produces a ... in healthy cells., The findings may help address ... ability to specifically and effectively target cancer cells. ... to insert "self-destruct" codes into the modified gene, ...
... Commonwealth University Life Sciences survey shows that eight in 10 ... who want it, and 54 percent say that the benefits ... about genetic research are varied with a plurality of 38 ... known about how to conduct such research safely. About three ...
Cached Biology News:No quick or easy technological fix for climate change, researchers say 2No quick or easy technological fix for climate change, researchers say 3No quick or easy technological fix for climate change, researchers say 4Modified gene targets cancer cells a thousand times more often than healthy cells 2Modified gene targets cancer cells a thousand times more often than healthy cells 3VCU survey: US public supports genetic research, testing and government spending on research 2VCU survey: US public supports genetic research, testing and government spending on research 3
... fast and reliable automation for today's ... development laboratories. Staccato Mini-Workstations offer the ... basic liquid handling and material management ... either Caliper's time proven CLARA™ assay ...
Experion StdSens chips are the microfluidic chips used to perform standard-sensitivity RNA analysis (nanogram levels) with the Experion automated electrophoresis system. Each chip has the capacity to...
... If particles in the submicron range ... development process, measurement and control of particle ... an analyzer that can reliably detect the ... The N5 Submicron Particle Size Analyzer uses ...
...
Biology Products: